Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating activities:    
Net loss $ (48,169) $ (49,048)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 98 50
Amortization of right of use assets 156
Stock-based compensation 351 562
Interest expense, net 58
Loss on impairment goodwill 46,103
Loss on impairment of in process research and development 53,905
Gain on settlement of mortgage note receivable (106)
Loss on disposal of property and equipment 60
Payments on operating lease liabilities (133)
Change in fair value of derivative liabilities (256) (306)
Gain on mortgage note receivable (106)
Deferred income tax benefit (13,582)
Changes in operating assets and liabilities:    
Accounts receivable (644)
Prepaid expenses and other current assets 22 (86)
Deposits (10) (9)
Accounts payable and accrued expenses 919 240
Deferred rent (28)
Net cash used in operating activities (1,563) (8,290)
Investing activities:    
Purchases of property and equipment (145) (28)
Proceeds from settlement of mortgage note receivable 1,400
Net cash (used in) provided by investing activities (145) 1,372
Financing activities:    
Payments of finance lease obligations (214) (19)
Proceeds from sale of common stock, net of transaction costs 6,638 7,684
Proceeds from issuance of convertible notes 1,000
Proceeds from exercise of stock options 228
Net cash provided by financing activities 6,424 8,893
Net increase in cash and restricted cash 4,716 1,975
Cash and restricted cash at beginning of period 2,752 777
Cash and restricted cash at end of period 7,468 2,752
Purchases of property and equipment under capital leases 347
Recognition of operating lease right-of-use assets and operating lease liabilities upon adoption of ASC Topic 842, Leases 833
Issuance of commons stock upon conversion of notes payable $ 2,062